HKD47.85
0.93% today
Hong Kong, Jul 22, 10:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2025 - Analyst rating & recommendation

JD Health International Classifications & Recommendation:

Buy
74%
Hold
22%
Sell
4%

JD Health International Price Target

Target Price HKD46.31
Price HKD47.85
Deviation
Number of Estimates 19
19 Analysts have issued a price target JD Health International 2026 . The average JD Health International target price is HKD46.31. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 17 Analysts recommend JD Health International to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2026 of . Most analysts recommend the JD Health International stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion HKD 63.62 73.96
8.65% 16.25%
EBITDA Margin 5.95% 4.17%
183.90% 29.91%
Net Margin 7.16% 6.80%
78.84% 4.97%

19 Analysts have issued a sales forecast JD Health International 2025 . The average JD Health International sales estimate is

HKD74.0b
Unlock
. This is
16.25% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD77.9b 22.40%
Unlock
, the lowest is
HKD69.2b 8.74%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD63.6b 8.65%
2025
HKD74.0b 16.25%
Unlock
2026
HKD82.8b 11.95%
Unlock
2027
HKD92.4b 11.58%
Unlock
2028
HKD104b 13.11%
Unlock
2029
HKD116b 10.87%
Unlock
2030
HKD128b 10.17%
Unlock
2031
HKD140b 9.81%
Unlock
2032
HKD153b 9.42%
Unlock

21 JD Health International Analysts have issued a net profit forecast 2025. The average JD Health International net profit estimate is

HKD5.0b
Unlock
. This is
10.55% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD5.6b 22.68%
Unlock
, the lowest is
HKD4.6b 0.64%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 HKD4.6b 94.31%
2025
HKD5.0b 10.55%
Unlock
2026
HKD5.7b 12.75%
Unlock
2027
HKD6.6b 16.07%
Unlock
2028
HKD6.5b 1.80%
Unlock
2029
HKD6.0b 7.76%
Unlock
2030
HKD7.1b 19.29%
Unlock
2031
HKD8.5b 19.90%
Unlock
2032
HKD9.9b 16.60%
Unlock

Net Margin

2024 7.16% 78.84%
2025
6.80% 4.97%
Unlock
2026
6.85% 0.74%
Unlock
2027
7.13% 4.09%
Unlock
2028
6.19% 13.18%
Unlock
2029
5.15% 16.80%
Unlock
2030
5.58% 8.35%
Unlock
2031
6.09% 9.14%
Unlock
2032
6.49% 6.57%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share HKD 1.44 1.57
94.59% 9.03%
P/E 30.70
EV/Sales 1.31

21 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International EPS is

HKD1.57
Unlock
. This is
9.03% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD1.75 21.53%
Unlock
, the lowest is
HKD1.43 0.69%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD1.44 94.59%
2025
HKD1.57 9.03%
Unlock
2026
HKD1.77 12.74%
Unlock
2027
HKD2.06 16.38%
Unlock
2028
HKD2.02 1.94%
Unlock
2029
HKD1.86 7.92%
Unlock
2030
HKD2.22 19.35%
Unlock
2031
HKD2.67 20.27%
Unlock
2032
HKD3.11 16.48%
Unlock

P/E ratio

Current 33.54 46.90%
2025
30.70 8.47%
Unlock
2026
27.23 11.30%
Unlock
2027
23.46 13.85%
Unlock
2028
23.89 1.83%
Unlock
2029
25.90 8.41%
Unlock
2030
21.71 16.18%
Unlock
2031
18.11 16.58%
Unlock
2032
15.53 14.25%
Unlock

Based on analysts' sales estimates for 2025, the JD Health International stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.52 560.87%
2025
1.31 13.82%
Unlock
2026
1.17 10.67%
Unlock
2027
1.05 10.38%
Unlock
2028
0.93 11.59%
Unlock
2029
0.84 9.80%
Unlock
2030
0.76 9.23%
Unlock
2031
0.69 8.93%
Unlock
2032
0.63 8.61%
Unlock

P/S ratio

Current 2.40 118.36%
2025
2.06 13.98%
Unlock
2026
1.84 10.67%
Unlock
2027
1.65 10.38%
Unlock
2028
1.46 11.59%
Unlock
2029
1.32 9.80%
Unlock
2030
1.20 9.23%
Unlock
2031
1.09 8.93%
Unlock
2032
1.00 8.61%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today